Vasa Denticity Ltd
Incorporated in 2016, Vasa Denticity Limited is in the business of marketing and distribution
of a comprehensive portfolio of Dental Products.[1]
- Market Cap ₹ 782 Cr.
- Current Price ₹ 447
- High / Low ₹ 612 / 322
- Stock P/E 65.0
- Book Value ₹ 109
- Dividend Yield 0.00 %
- ROCE 6.95 %
- ROE 4.51 %
- Face Value ₹ 10.0
Pros
- Company is almost debt free.
- Debtor days have improved from 20.4 to 15.9 days.
Cons
- Stock is trading at 4.11 times its book value
- Though the company is reporting repeated profits, it is not paying out dividend
- Promoter holding has decreased over last quarter: -0.54%
- Company has a low return on equity of 11.7% over last 3 years.
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Healthcare Healthcare Healthcare Equipment & Supplies Medical Equipment & Supplies
Part of Nifty SME Emerge
Quarterly Results
Consolidated Figures in Rs. Crores / View Standalone
Profit & Loss
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2024 3m | Mar 2025 | Mar 2026 | TTM | |
|---|---|---|---|---|
| 170 | 241 | 277 | 316 | |
| Sales growth | +42% | +15% | +17% | |
| 151 | 218 | 266 | 301 | |
| Operating Profit | 19 | 23 | 11 | 14 |
| OPM % | 11% | 10% | 4.0% | 4.5% |
| 1 | 2 | 5 | 4 | |
| Interest | 0 | 0 | 0 | 0 |
| Depreciation | 1 | 2 | 2 | 3 |
| Profit before tax | 19 | 23 | 13 | 16 |
| Tax % | 22% | 27% | 25% | |
| 15 | 17 | 10 | 12 | |
| EPS in Rs | 9.42 | 10.21 | 5.90 | 6.89 |
| Dividend Payout % | 0% | 0% | 0% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| TTM: | 17% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| TTM: | -23% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | -8% |
| 1 Year: | -27% |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | 12% |
| Last Year: | 5% |
Balance Sheet
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2024 | Mar 2025 | Mar 2026 | Sep 2026 | |
|---|---|---|---|---|
| Equity Capital | 16 | 17 | 17 | 17 |
| Reserves | 52 | 116 | 157 | 173 |
| 0 | 0 | 0 | 0 | |
| 17 | 19 | 23 | 30 | |
| Total Liabilities | 86 | 151 | 197 | 220 |
| 2 | 16 | 25 | 25 | |
| CWIP | 1 | 6 | 1 | 1 |
| Investments | 12 | 42 | 42 | 33 |
| 70 | 87 | 129 | 161 | |
| Total Assets | 86 | 151 | 197 | 220 |
Cash Flows
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|
| -11 | -4 | -25 | |
| -22 | -43 | -4 | |
| 36 | 47 | 30 | |
| Net Cash Flow | 3 | 1 | 0 |
| Free Cash Flow | -14 | -24 | -31 |
| CFO/EBITDA Share of operating profit converting into cash: CFO (before tax) / Operating Profit | -35% | 11% | -195% |
Ratios
Consolidated / View Standalone
| Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|
| Debtor Days | 24 | 21 | 16 |
| Inventory Days | 99 | 112 | 151 |
| Days Payable | 33 | 23 | 26 |
| Cash Conversion Cycle | 90 | 110 | 141 |
| Working Capital Days | 84 | 95 | 131 |
| ROCE % | 22% | 7% |
Insights
In beta| Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|
| Average Delivery Days days |
|
||||
| Number of Brands count |
|||||
| Number of SKUs count |
|||||
| Total Customer Base count |
|||||
| Total Orders count |
|||||
| Unique Customers Served count |
|||||
| Warehousing Space sq. ft. |
|||||
| 180-Day Customer Retention % ・Standalone data |
|||||
Extracted by Screener AI
Documents
Announcements
-
Analysts/Institutional Investor Meet/Con. Call Updates
- Conference call for Q2 and half-year ended September 30, 2026 on November 11, 2026.
-
Appointment
- Dr. Vikas Agarwal reappointed Managing Director for five years from 13 January 2027, pending shareholder approval.
-
Appointment
- Dr. Vikas Agarwal reappointed Managing Director from 13 Jan 2027 for five years, subject to shareholder approval.
-
Appointment
- Board approved reappointment of Independent Director Varun Chugh for five years from 6 Nov 2026, subject to shareholder approval.
-
Appointment
- Ravi Kant Jagetia reappointed as independent director for five years from November 6, 2026.
Annual reports
-
Annual Report 2026
from nse
-
Annual Report 2025
from nse
-
Annual Report 2024
from nse
-
Annual Report 2023
from nse
Concalls
-
Aug 2026Transcript PPT REC
-
Jun 2026Transcript
-
Nov 2025Transcript PPT
-
Aug 2025PPT
-
May 2025Transcript PPT
-
Mar 2025PPT
-
Nov 2024Transcript PPT
-
May 2024Transcript PPT
-
Nov 2023Transcript
-
Nov 2023Transcript PPT
-
Nov 2023PPT
Business Overview[1][2]
Vasa Denticity is a Dental Products e-commerce company with 20,000+ SKUs, 30 owned Brands, and 300+ Domestic and international Brand tie-ups. It specializes in Orthodontics, Endodontics, Oral Surgery, diagnosis, treatment, and aesthetics.[3]